ERBB2 and neoplasm: The siRNA-loaded OMVs can induce targeted gene silencing and significant inhibition of cell proliferation in HER2-overexpressing cell lines and tumor growth regression in tumor animal models rather than elicit their antitumor effects by overstimulating inflammatory or immunological pathways (Gujrati et al., 2014).